• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 4: Schinzing Alexander V converted options into 1,851,250 shares

    2/6/23 6:06:23 AM ET
    $FXCO
    Blank Checks
    Finance
    Get the next $FXCO alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
    1. Name and Address of Reporting Person*
    Schinzing Alexander V

    (Last) (First) (Middle)
    C/O FINANCIAL STRATEGIES ACQUISITION
    CORP., 2626 COLE AVENUE, SUITE 300

    (Street)
    DALLAS TX 75204

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    Financial Strategies Acquisition Corp. [ FXCO ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    Director X 10% Owner
    X Officer (give title below) Other (specify below)
    Chief Executive Officer
    3. Date of Earliest Transaction (Month/Day/Year)
    12/01/2022
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    Form filed by One Reporting Person
    X Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Class A Common Stock(1) 12/01/2022 C 775,000 A (1) 975,000 I See Footnote(2)(3)(4)(5)
    Class A Common Stock(1) 12/01/2022 C 416,212 A (1) 416,212 I See Footnote(2)(3)(4)(6)
    Class A Common Stock(1) 12/01/2022 C 375,000 A (1) 375,000 I See Footnote(2)(3)(4)(7)
    Class A Common Stock(1) 12/01/2022 C 200,000 A (1) 250,000 I See Footnote(2)(3)(4)(8)
    Class A Common Stock(1) 12/01/2022 C 85,038 A (1) 85,038 I See Footnote(2)(3)(4)(9)
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Class B Common Stock (1) 12/01/2022 C 775,000 (1) (1) Class A Common Stock 775,000 (1) 0 I See Footnote(2)(3)(4)(5)
    Class B Common Stock (1) 12/01/2022 C 416,212 (1) (1) Class A Common Stock 416,212 (1) 0 I See Footnote(2)(3)(4)(6)
    Class B Common Stock (1) 12/01/2022 C 375,000 (1) (1) Class A Common Stock 375,000 (1) 0 I See Footnote(2)(3)(4)(7)
    Class B Common Stock (1) 12/01/2022 C 200,000 (1) (1) Class A Common Stock 200,000 (1) 0 I See Footnote(2)(3)(4)(8)
    Class B Common Stock (1) 12/01/2022 C 85,038 (1) (1) Class A Common Stock 85,038 (1) 0 I See Footnote(2)(3)(4)(9)
    1. Name and Address of Reporting Person*
    Schinzing Alexander V

    (Last) (First) (Middle)
    C/O FINANCIAL STRATEGIES ACQUISITION
    CORP., 2626 COLE AVENUE, SUITE 300

    (Street)
    DALLAS TX 75204

    (City) (State) (Zip)
    1. Name and Address of Reporting Person*
    FSC Sponsor LLC

    (Last) (First) (Middle)
    C/O FINANCIAL STRATEGIES ACQUISITION
    CORP., 2626 COLE AVENUE, SUITE 300

    (Street)
    DALLAS TX 75204

    (City) (State) (Zip)
    1. Name and Address of Reporting Person*
    Celtic Asset & Equity Partners, Ltd.

    (Last) (First) (Middle)
    C/O FINANCIAL STRATEGIES ACQUISITION
    CORP., 2626 COLE AVENUE, SUITE 300

    (Street)
    DALLAS TX 75204

    (City) (State) (Zip)
    1. Name and Address of Reporting Person*
    Caliente Management L.L.C.

    (Last) (First) (Middle)
    C/O FINANCIAL STRATEGIES ACQUISITION
    CORP., 2626 COLE AVENUE, SUITE 300

    (Street)
    DALLAS TX 75204

    (City) (State) (Zip)
    Explanation of Responses:
    1. The Issuer's Class B Common Stock is convertible into Class A Common Stock at any time at the option of the holder, on a one-for-one basis, and has no expiration date.
    2. This statement is filed jointly by and on behalf of Mr. Schinzing, FSC Sponsor LLC ("FSC Sponsor"), Celtic Asset & Equity Partners, Ltd. ("Celtic A&E") and Caliente Management L.L.C. ("Caliente"). FSC Sponsor, Celtic A&E, Caliente, Celtic Sponsor VII LLC ("Celtic Sponsor VII") and Frio Investments L.L.C. ("Frio") are the direct beneficial owners of the securities covered by this statement.
    3. FSC Sponsor is the managing member of, and may be deemed to beneficially own securities owned by, Caliente and Frio. Mr. Schinzing is the managing member of FSC Sponsor and Celtic A&E and the manager of Celtic Sponsor VII. Therefore, Mr. Schinzing may be deemed to beneficially own securities owned by each of FSC Sponsor, Celtic A&E, Caliente, Frio and Celtic Sponsor VII.
    4. The reporting persons state that neither the filing of this statement nor anything herein shall be deemed an admission that such persons are, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the ?Exchange Act?), or otherwise, the beneficial owners of any securities covered by this statement. The reporting persons disclaim beneficial ownership of the securities covered by this statement, except to the extent of the pecuniary interest of such persons in such securities.
    5. Represents shares directly beneficially owned by FSC Sponsor.
    6. Represents shares directly beneficially owned by Celtic A&E.
    7. Represents shares directly beneficially owned by Caliente.
    8. Represents shares directly beneficially owned by Celtic Sponsor VII.
    9. Represents shares directly beneficially owned by Frio.
    /s/ Alexander V. Schinzing 02/06/2023
    Celtic Asset & Equity Partners, Ltd.; By: /s/ Alexander V. Schinzing 02/06/2023
    FSC Sponsor LLC; By: /s/ Alexander V. Schinzing 02/06/2023
    Caliente Management L.L.C.; By: FSC Sponsor LLC, its managing member; By: /s/ Alexander V. Schinzing 02/06/2023
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $FXCO alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $FXCO

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $FXCO
    SEC Filings

    View All

    SEC Form 25-NSE filed by Financial Strategies Acquisition Corp.

    25-NSE - Financial Strategies Acquisition Corp. (0001817565) (Subject)

    11/20/23 8:45:34 AM ET
    $FXCO
    Blank Checks
    Finance

    Financial Strategies Acquisition Corp. filed SEC Form 8-K: Changes in Registrant’s Certifying Accountant, Financial Statements and Exhibits

    8-K - Financial Strategies Acquisition Corp. (0001817565) (Filer)

    8/11/23 4:00:25 PM ET
    $FXCO
    Blank Checks
    Finance

    Financial Strategies Acquisition Corp. filed SEC Form 8-K: Creation of a Direct Financial Obligation, Financial Statements and Exhibits

    8-K - Financial Strategies Acquisition Corp. (0001817565) (Filer)

    6/15/23 4:02:24 PM ET
    $FXCO
    Blank Checks
    Finance

    $FXCO
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Financial Strategies Acquisition Corp. Announces Merger with Austin Biosciences Corp, A Texas Biotechnology Platform Company

    DALLAS and AUSTIN, Texas, Feb. 13, 2023 /PRNewswire/ -- Financial Strategies Acquisition Corp. (NASDAQ:FXCO) ("FXCO")(the "Company")., a Special Purpose Acquisition Company led by CEO Alexander V. Schinzing, today announced the execution of a definitive business combination agreement with Austin Biosciences Corp. ("Austin Biosciences"). Upon closing of the transaction, Austin Biosciences will become a wholly-owned subsidiary of the Company. Mr. Schinzing will serve as Chairman and Mr. Burgi-Krishnamurthy will serve as Chief Executive Officer of Austin Biosciences. The Company'

    2/13/23 4:29:00 PM ET
    $FXCO
    Blank Checks
    Finance

    Financial Strategies Acquisition Corp. Announces Extension of Termination Date and Additional Contribution to Trust Account to Extend Termination Date

    DALLAS, Feb. 9, 2023 /PRNewswire/ -- Financial Strategies Acquisition Corp. (NASDAQ:FXCO, the ", Company", ))), a special purpose acquisition company, announced today that its Board of Directors (the "Board") has approved an extension of the period of time available to the Company to consummate an initial business combination by one month from February 14, 2023 to March 14, 2023 (the "Termination Date"), as permitted under the Company's amended and restated certificate of incorporation, as amended. The purpose of the extension is to provide additional time for the Company to complete an initial business combination.

    2/9/23 5:33:00 PM ET
    $FXCO
    Blank Checks
    Finance

    Financial Strategies Acquisition Corp. Announces Extension of Termination Date and Additional Contribution to Trust Account to Extend Termination Date

    DALLAS, Jan. 11, 2023 /PRNewswire/ -- Financial Strategies Acquisition Corp. (NASDAQ:FXCO, the ", Company", ))), a special purpose acquisition company, announced today that its Board of Directors (the "Board") has approved an extension of the period of time available to the Company to consummate an initial business combination by one month from January 14, 2023 to February 14, 2023 (the "Termination Date"), as permitted under the Company's amended and restated certificate of incorporation, as amended. The purpose of the extension is to provide additional time for the Company to complete an initial business combination. In connection with the extension, Temmelig Investor LLC, an affiliate of

    1/11/23 4:30:00 PM ET
    $FXCO
    Blank Checks
    Finance

    $FXCO
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4: Schinzing Alexander V converted options into 1,851,250 shares

    4 - Financial Strategies Acquisition Corp. (0001817565) (Issuer)

    2/6/23 6:06:23 AM ET
    $FXCO
    Blank Checks
    Finance

    SEC Form 3 filed by new insider Vainionpaa Timo

    3 - Financial Strategies Acquisition Corp. (0001817565) (Issuer)

    6/21/22 5:26:50 PM ET
    $FXCO
    Blank Checks
    Finance

    SEC Form 3 filed by new insider Minkowitz Daniel

    3 - Financial Strategies Acquisition Corp. (0001817565) (Issuer)

    6/21/22 5:25:59 PM ET
    $FXCO
    Blank Checks
    Finance

    $FXCO
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Financial Strategies Acquisition Corp. (Amendment)

    SC 13G/A - Financial Strategies Acquisition Corp. (0001817565) (Subject)

    2/5/24 3:11:44 PM ET
    $FXCO
    Blank Checks
    Finance

    SEC Form SC 13G filed by Financial Strategies Acquisition Corp.

    SC 13G - Financial Strategies Acquisition Corp. (0001817565) (Subject)

    2/21/23 12:30:49 PM ET
    $FXCO
    Blank Checks
    Finance

    SEC Form SC 13G/A filed by Financial Strategies Acquisition Corp. (Amendment)

    SC 13G/A - Financial Strategies Acquisition Corp. (0001817565) (Subject)

    2/14/23 10:27:21 AM ET
    $FXCO
    Blank Checks
    Finance